A Multicentre Parallel Group Open Label Nonrandomized Observational Study To Evaluate The Safety And Efficacy Of Premix Insulin And Some Oral Hypoglycemic Agents In Type 2 Diabetes Mellitus Treatment Its Impact On Standard Of Care

Abstract

None newline

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced